# A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers

> **NCT01796327** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 14 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** dacomitinib oral
- **DRUG:** dacomitinib intravenous

## Key facts

- **NCT ID:** NCT01796327
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796327, "A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01796327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*